Sophie Lai

Medical Monitor – Global Clinical Development @ BioVersys AG

About

Swiss, UK, and HK registered physician with 7+ years of clinical and academic experience across paediatrics, immunology, allergy, vaccinology, and infectious diseases. Clinically trained specialist with extensive experience in hospital-based research, medical-scientific communication, multidisciplinary collaboration, and evidence-based care. Further trained in Digital Health and Digital Clinical Trials at ETH Zurich, with expertise in study design, decentralized trials, digital biomarkers, real-world data, and digital therapeutics. Passionate about applying clinical insight to strategic, data-driven decision-making that advances patient-centred innovation across the life sciences sector. Currently working at Bioversys as a Medical Monitor, supporting global Phase II–III clinical trials in infectious diseases while building industry experience in clinical drug development, medical monitoring, and the development of novel therapies addressing antimicrobial resistance.

Country

Switzerland

City

Zurich

Industry

Hospital & Health Care

Skill

Cross-functional Coordination, Dermatology, Biologics, Medical Education, Oncology, English, Digital Health, Patient Outcomes, Good Clinical Practice (GCP), Medical Science, Research Skills, Clinical Trials, Paediatrics (General & Subspecialties), Paediatric Immunology, Clinical Research, Digital Health Innovation, Digital Clinical Trials, Clinical Study Design & Execution, Digital Biomarkers & Wearables, Digital Therapeutics (DTx)

Experience

Medical Monitor – Global Clinical Development

BioVersys AG

2026-2 - Present · 8 mos

Basel, Switzerland

Driving medical oversight for global Phase II–III clinical trials in infectious diseases, combining clinical expertise with hands-on trial execution to advance innovative therapies targeting antimicrobial resistance.

Clinical Observership in Paediatric Allergy & Immunology

Kinderspital Zürich

2025-9 - 2026-2 · 6 mos

Zurich, Switzerland

• Gained insight into the structure and clinical workflows of the Swiss paediatric healthcare system, including interdisciplinary collaboration, referral pathways, and the integration of specialised tertiary care services. • Developed hands-on understanding of diagnostic approaches in allergy and immunology, including diagnostics, immunotherapy strategies, desentization and management of primary immunodeficiencies.

Specialist Paediatrician

Queen Mary Hospital

2023-10 - 2024-12 · 1 yr 3 mos

Hong Kong SAR

Pediatric Resident

Queen Mary Hospital

2016-7 - 2023-9 · 7 yrs 3 mos

Honorary Clinical Tutor

The University of Hong Kong

2017-7 - 2024-12 · 7 yrs 6 mos

Hong Kong SAR

Education

ETH Zürich

Digital Health

2025-2 - 2026-2 · 1 yr 1 mo

• Development and integration of digital strategies and treatments • Evaluation of digital health solutions focusing on the integration of AI capabilities • Personalised measurements

ETH Zürich

Digital Clinical Trials

2025-9 - 2026-6 · 10 mos

• Transforming research ideas into a comprehensive clinical research approach utilising novel, digital technologies. • Designing a digital clinical study while integrating modern study concepts, digital measures, precision medicine, AI applications, real-world data and digital health technology

University of Zurich

UMZH Precision Digital Therapeutics (PDTx) Summer School

2025-8 - 2025-8 · 1 mo

Designing and developing Precision Digital Therapeutics (PDTx) – hyper-personalized, software-based interventions for disease management and treatment. Key highlights: • Collaborated with clinical experts, caregivers, and patients to tackle real-world challenges in the Swiss healthcare system • Built a working PDTx prototype in interdisciplinary teams, applying cutting-edge GenAI tools and digital health frameworks • Engaged in lectures and coaching sessions with international experts across medicine, technology, and business • Presented the prototype to a jury of clinicians, patients, and investors, with the aim of creating both business and societal impact